[Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment].

I V Kolykhalov L V Androsova Svetlana I Gavrilova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

This study shows high significance of further research in assessing the role of immune mechanisms of α-GPC therapeutic efficacy in aMCI patients and the possibility of using immunological parameters as prognostic markers of its therapeutic effect.

Keyphrases

mild cognitive impairment
cognitive decline
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors